CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.96
-2.72 (-4.21%)
Nov 2, 2026, 4:00 PM EST - Market closed
CG Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Initiates $90 | Buy | Initiates | $90 | +45.26% | Oct 22, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 10, 2026 |
| UBS | UBS | Buy Reiterates $90 | Buy | Reiterates | $90 | +45.26% | Aug 20, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 | Buy | Reiterates | $93 | +50.10% | Aug 17, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $108 | Buy | Maintains | $108 | +74.31% | Aug 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $105 | Buy | Reiterates | $105 | +69.46% | Aug 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $82 → $85 | Buy | Reiterates | $82 → $85 | +37.19% | Aug 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $81 → $79 | Buy | Maintains | $81 → $79 | +27.50% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.